MEP32308A - Pharmaceutical composition containing histone deacetylase inhibitor - Google Patents
Pharmaceutical composition containing histone deacetylase inhibitorInfo
- Publication number
- MEP32308A MEP32308A MEP-323/08A MEP32308A MEP32308A ME P32308 A MEP32308 A ME P32308A ME P32308 A MEP32308 A ME P32308A ME P32308 A MEP32308 A ME P32308A
- Authority
- ME
- Montenegro
- Prior art keywords
- histone deacetylase
- deacetylase inhibitor
- pharmaceutical composition
- composition containing
- containing histone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003148073 | 2003-05-26 | ||
PCT/JP2004/007562 WO2004103369A1 (en) | 2003-05-26 | 2004-05-26 | Pharmaceutical composition containing histone deacetylase inhibitor |
YUP-2005/0884A RS20050884A (en) | 2003-05-26 | 2004-05-26 | Pharmaceutical composition containing histone deacetylase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP32308A true MEP32308A (en) | 2010-10-10 |
Family
ID=33475383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-323/08A MEP32308A (en) | 2003-05-26 | 2004-05-26 | Pharmaceutical composition containing histone deacetylase inhibitor |
Country Status (27)
Country | Link |
---|---|
US (1) | US20070098816A1 (pt) |
EP (1) | EP1626719A1 (pt) |
JP (1) | JP2006526031A (pt) |
KR (1) | KR100938712B1 (pt) |
CN (2) | CN101322707A (pt) |
AR (1) | AR045318A1 (pt) |
AU (1) | AU2004241873C1 (pt) |
BR (1) | BRPI0410959A (pt) |
CA (4) | CA2634709A1 (pt) |
CL (1) | CL2004001278A1 (pt) |
CO (1) | CO5660262A2 (pt) |
CR (1) | CR8163A (pt) |
CU (1) | CU23490B7 (pt) |
EC (1) | ECSP056253A (pt) |
IL (1) | IL171941A0 (pt) |
ME (1) | MEP32308A (pt) |
MX (1) | MXPA05012345A (pt) |
NO (1) | NO20055417L (pt) |
NZ (1) | NZ543591A (pt) |
PE (1) | PE20050206A1 (pt) |
RS (1) | RS20050884A (pt) |
RU (1) | RU2322971C2 (pt) |
TW (1) | TW200505424A (pt) |
UA (1) | UA81499C2 (pt) |
UY (1) | UY28330A1 (pt) |
WO (1) | WO2004103369A1 (pt) |
ZA (1) | ZA200509515B (pt) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
US7244853B2 (en) | 2001-05-09 | 2007-07-17 | President And Fellows Of Harvard College | Dioxanes and uses thereof |
ES2344899T3 (es) | 2003-09-25 | 2010-09-09 | Astellas Pharma Inc. | Agente antitumoral que comprende un inhibidor de histona desacetilasa y un inhibidor de topoisomerasa ii. |
US7446126B2 (en) * | 2004-10-08 | 2008-11-04 | Indena S.P.A. | Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel |
EP1712552A1 (en) * | 2005-04-11 | 2006-10-18 | INDENA S.p.A. | Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
KR20150008926A (ko) * | 2005-03-11 | 2015-01-23 | 더 리전츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코퍼레이트 | 암 세포를 표피 성장 인자 억제제에 대해 감작화시키는 히스톤 데아세틸라제 억제제 |
WO2006102557A2 (en) | 2005-03-22 | 2006-09-28 | The President And Fellows Of Harvard College | Treatment of protein degradation disorders |
US7732475B2 (en) | 2005-07-14 | 2010-06-08 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US8222423B2 (en) | 2006-02-14 | 2012-07-17 | Dana-Farber Cancer Institute, Inc. | Bifunctional histone deacetylase inhibitors |
MX2008010462A (es) * | 2006-02-14 | 2009-04-17 | Harvard College | Inhibidores de histona desacetilasa. |
AU2007248656B2 (en) | 2006-05-03 | 2013-04-04 | Dana-Farber Cancer Institute, Inc. | Histone deacetylase and tubulin deacetylase inhibitors |
GB0625283D0 (en) * | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
AU2007340129B2 (en) * | 2006-12-26 | 2012-02-02 | Pharmacyclics Llc | Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
US20090131367A1 (en) * | 2007-11-19 | 2009-05-21 | The Regents Of The University Of Colorado | Combinations of HDAC Inhibitors and Proteasome Inhibitors |
WO2009079375A1 (en) * | 2007-12-14 | 2009-06-25 | Georgetown University | Histone deacetylase inhibitors |
WO2010011296A2 (en) | 2008-07-23 | 2010-01-28 | President And Fellows Of Harvard College | Deacetylase inhibitors and uses thereof |
NZ591387A (en) * | 2008-08-29 | 2012-03-30 | Bayer Pharma AG | N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275) polymorph b |
GB2462893B (en) * | 2008-08-29 | 2010-10-13 | Bayer Schering Pharma Ag | N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B |
US8841308B2 (en) | 2008-12-19 | 2014-09-23 | Vertex Pharmaceuticals Incorporated | Pyrazin-2-amines useful as inhibitors of ATR kinase |
US20120034302A1 (en) * | 2009-02-11 | 2012-02-09 | Liangping Yu | Particulate composition and the method of making the same |
WO2010125462A2 (en) * | 2009-05-01 | 2010-11-04 | Oncozyme Pharma Inc. | Pentamidine combinations for treating cancer |
WO2010144371A1 (en) * | 2009-06-08 | 2010-12-16 | Gilead Colorado, Inc. | Alkanoylamino benzamide aniline hdac inihibitor compounds |
WO2011019393A2 (en) | 2009-08-11 | 2011-02-17 | President And Fellows Of Harvard College | Class- and isoform-specific hdac inhibitors and uses thereof |
UA110196C2 (uk) * | 2009-08-25 | 2015-12-10 | Абраксіс Байосайєнс, Елелсі | Комбінована терапія композиціями наночастинок таксану і інгібіторами хеджхог |
EP2569313A1 (en) | 2010-05-12 | 2013-03-20 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
ES2627820T3 (es) | 2011-09-13 | 2017-07-31 | Pharmacyclics, Inc. | Formulaciones de inhibidor de histona desacetilasa en combinación con bendamustina y usos de las mismas |
US9035053B2 (en) | 2011-09-30 | 2015-05-19 | Vertex Pharmaceuticals Incorporated | Processes for making compounds useful as inhibitors of ATR kinase |
SG11201401095YA (en) * | 2011-09-30 | 2014-04-28 | Vertex Pharma | Treating pancreatic cancer and non-small cell lung cancer with atr inhibitors |
WO2013085902A1 (en) * | 2011-12-05 | 2013-06-13 | The University Of Texas M.D. | Combination therapy methods for treating an inflammatory breast cancer |
LT2833973T (lt) | 2012-04-05 | 2018-02-12 | Vertex Pharmaceuticals Incorporated | Junginiai, tinkami naudoti kaip atr kinazės inhibitoriai, ir jų kombinuotas gydymas |
EP2904406B1 (en) | 2012-10-04 | 2018-03-21 | Vertex Pharmaceuticals Incorporated | Method for measuring atr inhibition mediated increases in dna damage |
CA2903473A1 (en) | 2013-03-12 | 2014-10-09 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
WO2014141129A2 (en) * | 2013-03-14 | 2014-09-18 | Grueneberg Dorre A | Novel methods, compounds, and compositions for inhibition of ros |
EA201592012A8 (ru) * | 2014-02-21 | 2018-10-31 | Общество С Ограниченной Ответственностью "Биолаб 612" | Применение флагеллина для улучшенной химиотерапии |
WO2016044138A1 (en) | 2014-09-17 | 2016-03-24 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
US11464774B2 (en) | 2015-09-30 | 2022-10-11 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
US11596612B1 (en) | 2022-03-08 | 2023-03-07 | PTC Innovations, LLC | Topical anesthetics |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
US6794392B1 (en) * | 1996-09-30 | 2004-09-21 | Schering Aktiengesellschaft | Cell differentiation inducer |
JP3354090B2 (ja) | 1996-09-30 | 2002-12-09 | シエーリング アクチエンゲゼルシャフト | 分化誘導剤 |
US6174905B1 (en) * | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
US5753637A (en) * | 1996-10-09 | 1998-05-19 | Ideal Ideas, Inc. | Method of treating acne conditions |
AP2001002109A0 (en) * | 1998-09-25 | 2001-03-31 | Warner Lambert Co | Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin. |
KR100812972B1 (ko) * | 1999-04-27 | 2008-03-13 | 미쯔비시 웰 파마 가부시키가이샤 | 간질환 예방/치료제 |
CA2386876A1 (en) * | 1999-11-10 | 2001-05-17 | Warner-Lambert Company | Combination chemotherapy |
US6905669B2 (en) * | 2001-04-24 | 2005-06-14 | Supergen, Inc. | Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase |
CZ20022216A3 (cs) * | 2001-07-02 | 2003-05-14 | Warner-Lambert Company | Kombinační chemoterapie |
JP2003137866A (ja) * | 2001-11-01 | 2003-05-14 | Sankyo Co Ltd | フェニレンジアミン誘導体 |
-
2004
- 2004-05-25 PE PE2004000533A patent/PE20050206A1/es not_active Application Discontinuation
- 2004-05-26 CA CA002634709A patent/CA2634709A1/en not_active Abandoned
- 2004-05-26 CN CNA2008101007303A patent/CN101322707A/zh active Pending
- 2004-05-26 RU RU2005140570/15A patent/RU2322971C2/ru active IP Right Revival
- 2004-05-26 KR KR1020057022615A patent/KR100938712B1/ko not_active IP Right Cessation
- 2004-05-26 CL CL200401278A patent/CL2004001278A1/es unknown
- 2004-05-26 EP EP04734923A patent/EP1626719A1/en not_active Withdrawn
- 2004-05-26 ME MEP-323/08A patent/MEP32308A/xx unknown
- 2004-05-26 JP JP2006519178A patent/JP2006526031A/ja active Pending
- 2004-05-26 CA CA002527191A patent/CA2527191A1/en not_active Abandoned
- 2004-05-26 AU AU2004241873A patent/AU2004241873C1/en not_active Ceased
- 2004-05-26 US US10/558,208 patent/US20070098816A1/en not_active Abandoned
- 2004-05-26 WO PCT/JP2004/007562 patent/WO2004103369A1/en active Application Filing
- 2004-05-26 RS YUP-2005/0884A patent/RS20050884A/sr unknown
- 2004-05-26 BR BRPI0410959-7A patent/BRPI0410959A/pt not_active IP Right Cessation
- 2004-05-26 UA UAA200512454A patent/UA81499C2/xx unknown
- 2004-05-26 CA CA002634765A patent/CA2634765A1/en not_active Abandoned
- 2004-05-26 NZ NZ543591A patent/NZ543591A/en unknown
- 2004-05-26 CN CNA2004800146332A patent/CN1794991A/zh active Pending
- 2004-05-26 MX MXPA05012345A patent/MXPA05012345A/es active IP Right Grant
- 2004-05-26 CA CA002634766A patent/CA2634766A1/en not_active Abandoned
- 2004-05-26 AR ARP040101807A patent/AR045318A1/es not_active Application Discontinuation
- 2004-05-26 TW TW093114934A patent/TW200505424A/zh unknown
- 2004-05-26 UY UY28330A patent/UY28330A1/es not_active Application Discontinuation
-
2005
- 2005-11-14 IL IL171941A patent/IL171941A0/en unknown
- 2005-11-16 NO NO20055417A patent/NO20055417L/no not_active Application Discontinuation
- 2005-11-24 ZA ZA200509515A patent/ZA200509515B/en unknown
- 2005-11-25 CU CU20050237A patent/CU23490B7/es not_active IP Right Cessation
- 2005-12-22 CO CO05129159A patent/CO5660262A2/es unknown
- 2005-12-26 EC EC2005006253A patent/ECSP056253A/es unknown
-
2006
- 2006-01-02 CR CR8163A patent/CR8163A/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP32308A (en) | Pharmaceutical composition containing histone deacetylase inhibitor | |
NO20055216L (no) | Nye hydroksamater som terapeutiske midler | |
ECSP20027480A (es) | Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa | |
BRPI0410727A (pt) | composto, composição farmacêutica, e, uso de um composto | |
NO20044135L (no) | Piperazinyl-, piperidinyl- og morfolinylderivater som nye inhibitorer av histon-deacetylase | |
NO20044146L (no) | Karbonylaminoderivater som nye inhibitorer av histon-deacetylase | |
EA200700143A1 (ru) | Производные замещенного пропенилпиперазина в качестве новых ингибиторов гистондеацетилазы | |
NO20044444L (no) | Benzamidderivater nyttige som histondeacetylase inhibitorer | |
CY1126110T1 (el) | Παραγωγα βενζοϋδροξαμικου οξεος ως εκλεκτικοι αναστολε1σ του hdac6 | |
AR042851A1 (es) | Acidos hidroxamicos inhibidores de histona desacetilasa | |
EA200701970A1 (ru) | Гидроксаматы как ингибиторы гистондеацетилазы и содержащие их фармацевтические композиции | |
AR117655A1 (es) | Composición farmacéutica para administración oral que comprende derivado de aminopirimidina o su sal | |
MX342041B (es) | Formulacion farmaceutica para inhibidores de histona desacetilasa. | |
SV2006002109A (es) | Una composicion farmaceutica antimicobacteriana | |
ATE373636T1 (de) | Amidderivate als inhibitoren der enzymatischen aktivität von renin | |
EP4136085A4 (en) | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE-6 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
EP4110780A4 (en) | COMPOUNDS DERIVED FROM 1,3,4-OXADIAZOLE USED AS HISTONE DEACETYLASE 6 INHIBITORS, AND PHARMACEUTICAL COMPOSITION COMPRISING THEM | |
EA201170950A1 (ru) | Новая комбинация активных ингредиентов, содержащая нестероидное противовоспалительное лекарственное средство и производное колхикозида | |
EA201992296A1 (ru) | Производные хиноксалина и пиридопиразина в качестве ингибиторов pi3k-бета | |
TH81162A (th) | สารผสมทางเภสัชกรรมที่มีตัวยับยั้งฮิสโตนดีอะซีทิลเลส | |
PE20212078A1 (es) | Inhibidor de mpges 1 para el tratamiento de dolor de osteoartritis | |
TH81162B (th) | สารผสมทางเภสัชกรรมที่มีตัวยับยั้งฮิสโตนดีอะซีทิลเลส | |
PE20040532A1 (es) | Formulacion medicamentosa a base de fexofenadina | |
NO20044224L (no) | Sulfonylaminoderivater som nye inhibitorer av histon-deacetylase |